Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ADMA BIOLOGICS, INC. (ADMA)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 72.6% | 73.5% | 77.1% | 81.1% | 86.1% | 93.0% | 98.6% | 110.9% |
| Gross profit | 27.4% | 26.5% | 22.9% | 18.9% | 13.9% | 7.0% | 1.4% | -10.9% |
| Selling, general and administrative | 26.7% | 29.3% | | 38.5% | 43.7% | 49.5% | | 59.1% |
| Research and development | 2.1% | 2.1% | 2.3% | 2.5% | 2.7% | 3.5% | 4.5% | 5.7% |
| General and administrative | | | 9.0% | | | | 14.5% | |
| Depreciation | 3.5% | 3.8% | 4.2% | 4.6% | 5.0% | 5.5% | 5.9% | 6.6% |
| EBITA | -7.7% | -13.6% | -25.1% | -35.1% | -46.2% | -61.0% | -71.2% | -90.0% |
| Amortization of intangibles | 0.3% | 0.4% | 0.5% | 0.5% | 0.6% | 0.8% | 0.9% | 1.0% |
| EBIT | -8.0% | -13.9% | -25.5% | -35.6% | -46.9% | -61.7% | -72.1% | -91.1% |
| Pre-tax income | -19.4% | -26.2% | -42.8% | -53.9% | -66.4% | -83.3% | -88.5% | -108.6% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -19.4% | -26.2% | -42.8% | -53.9% | -66.4% | -83.3% | -88.5% | -108.6% |
|